The @HumanVaccineProject lab mtg is today is Shane Crotty from La Jolla Institute is speaking on T cell immunity for COVID. 100% of survivors make CD4 resps., 70% CD8 against broad viral antigens. And never-infected make CD4 reaps based on Common Cold histories.
Here's my take on this:
- the immune response to #COVID19 involves both antibodies & the T cellular arm of the system;
- blood samples from pre-COVID 2015 show high levels of reacting T cells (CD4 & CD8): Why?
- it's likely T-cell reactions to common cold viruses, not COVID
MORE
- the immune response to #COVID19 involves both antibodies & the T cellular arm of the system;
- blood samples from pre-COVID 2015 show high levels of reacting T cells (CD4 & CD8): Why?
- it's likely T-cell reactions to common cold viruses, not COVID
MORE
Are the high reactions anti-common cold good news or bad for #COVID19 vaccines & long term immunity for survivors? Well, it's clear an effective #vaccine will need to trigger BOTH antibody & T cell resps.
BUT common colds circulate all the time, and despite having had..
MORE
BUT common colds circulate all the time, and despite having had..
MORE
..a cold one year, most of us keep catching colds throughout life.
So #coronavirus immune responses may not be robust, or long lasting.
This makes everything about #SARCoV2 vaccine R&D way more complicated.
Most vaccines simply aim to conjure IgG antibodies, & that works.
MORE
So #coronavirus immune responses may not be robust, or long lasting.
This makes everything about #SARCoV2 vaccine R&D way more complicated.
Most vaccines simply aim to conjure IgG antibodies, & that works.
MORE
Another finding is that IgA antibodies seem to be crucial to fighting #COVID19 which is unusual & mysterious. An effective vax will need to trigger IgA.
This combination of issues -- T cell response, cross reaction w/common colds, possibly short duration of protection..
MORE
This combination of issues -- T cell response, cross reaction w/common colds, possibly short duration of protection..
MORE
...& the mysterious need for what may be IgA antibodies working in concert w/IgG is why #TonyFauci has warned against excessive #COVID19 #vaccine optimism.
Yes, he says, we may have a product soon. But it might not protect ppl much better than immune syst protects against colds.
Yes, he says, we may have a product soon. But it might not protect ppl much better than immune syst protects against colds.